{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:21:12Z","timestamp":1773199272074,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["2023YFC0871000"],"award-info":[{"award-number":["2023YFC0871000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-03847-2","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:17:20Z","timestamp":1747282640000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Taurultam shows antiviral activity against SARS-CoV-2 and influenza virus"],"prefix":"10.1186","volume":"25","author":[{"given":"Rongbo","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beilei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingshuo","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingjun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junkui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiecheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"issue":"1","key":"3847_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jiph.2022.11.024","volume":"16","author":"K Dhama","year":"2023","unstructured":"Dhama K, et al. Global emerging Omicron variant of SARS-CoV-2: impacts, challenges and strategies. J Infect Public Health. 2023;16(1):4\u201314.","journal-title":"J Infect Public Health"},{"issue":"1","key":"3847_CR2","doi-asserted-by":"publisher","first-page":"21259","DOI":"10.1038\/s41598-021-00809-2","volume":"11","author":"T Kinoshita","year":"2021","unstructured":"Kinoshita T, et al. Co-infection of SARS-CoV-2 and influenza virus causes more severe and prolonged pneumonia in hamsters. Sci Rep. 2021;11(1):21259.","journal-title":"Sci Rep"},{"issue":"4","key":"3847_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41422-021-00473-1","volume":"31","author":"L Bai","year":"2021","unstructured":"Bai L, et al. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity. Cell Res. 2021;31(4):395\u2013403.","journal-title":"Cell Res"},{"issue":"9","key":"3847_CR4","doi-asserted-by":"publisher","first-page":"4406","DOI":"10.1002\/jmv.27870","volume":"94","author":"W Zhang","year":"2022","unstructured":"Zhang W, et al. Frequency and distribution of H1N1 influenza A viruses with oseltamivir-resistant mutations worldwide before and after the 2009 pandemic. J Med Virol. 2022;94(9):4406\u201316.","journal-title":"J Med Virol"},{"issue":"1","key":"3847_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1756-9966-29-21","volume":"29","author":"AM Chromik","year":"2010","unstructured":"Chromik AM, et al. Comparative analysis of cell death induction by taurolidine in different malignant human cancer cell lines. J Exp Clin Cancer Res. 2010;29(1):21.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"3847_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ijantimicag.2004.06.006","volume":"24","author":"M Koldehoff","year":"2004","unstructured":"Koldehoff M, Zakrzewski JL. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2004;24(5):491\u20135.","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"3847_CR7","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1002\/bjs.1800810743","volume":"81","author":"DM Baker","year":"1994","unstructured":"Baker DM, et al. Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery. Br J Surg. 1994;81(7):1054\u20136.","journal-title":"Br J Surg"},{"key":"3847_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/1471-2334-8-102","volume":"8","author":"A Simon","year":"2008","unstructured":"Simon A, et al. Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients. BMC Infect Dis. 2008;8:102.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"3847_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.virs.2022.11.010","volume":"38","author":"C Lv","year":"2023","unstructured":"Lv C, et al. Taurolidine improved protection against highly pathogenetic avian influenza H5N1 virus lethal-infection in mouse model by regulating the NF-kappaB signaling pathway. Virol Sin. 2023;38(1):119\u201327.","journal-title":"Virol Sin"},{"issue":"6","key":"3847_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1177\/0091270007299929","volume":"47","author":"L Gong","year":"2007","unstructured":"Gong L, et al. The pharmacokinetics of taurolidine metabolites in healthy volunteers. J Clin Pharmacol. 2007;47(6):697\u2013703.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"3847_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13020-023-00843-4","volume":"18","author":"R Luo","year":"2023","unstructured":"Luo R, et al. A potential Chinese medicine monomer against influenza A virus and influenza B virus: isoquercitrin. Chin Med. 2023;18(1):144.","journal-title":"Chin Med"},{"issue":"10353","key":"3847_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0140-6736(22)00982-5","volume":"400","author":"TM Uyeki","year":"2022","unstructured":"Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS. Influenza Lancet. 2022;400(10353):693\u2013706.","journal-title":"Influenza Lancet"},{"issue":"1","key":"3847_CR13","doi-asserted-by":"publisher","first-page":"e2373","DOI":"10.1002\/rmv.2373","volume":"33","author":"S Silva","year":"2023","unstructured":"Silva S, et al. Recent insights into SARS-CoV-2 Omicron variant. Rev Med Virol. 2023;33(1):e2373.","journal-title":"Rev Med Virol"},{"issue":"6","key":"3847_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2165\/00003088-200746060-00005","volume":"46","author":"R Stendel","year":"2007","unstructured":"Stendel R, et al. Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS\/MS of the derivatives taurultame and taurinamide in glioblastoma patients. Clin Pharmacokinet. 2007;46(6):513\u201324.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"3847_CR15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1756-9966-32-74","volume":"32","author":"K Marley","year":"2013","unstructured":"Marley K, et al. Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma. J Exp Clin Cancer Res. 2013;32(1):74.","journal-title":"J Exp Clin Cancer Res"},{"key":"3847_CR16","doi-asserted-by":"crossref","unstructured":"Giaccardi M et al. Salvage of cardiac implantable electronic device pocket infection with skin Erosion in frail 92-Year-Old. J Cardiovasc Dev Dis, 2022. 9(3).","DOI":"10.3390\/jcdd9030081"},{"issue":"4","key":"3847_CR17","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1245\/s10434-009-0867-9","volume":"17","author":"PM Neary","year":"2010","unstructured":"Neary PM, et al. The evolving role of taurolidine in cancer therapy. Ann Surg Oncol. 2010;17(4):1135\u201343.","journal-title":"Ann Surg Oncol"},{"key":"3847_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/2277-9175.142314","volume":"3","author":"S Ashkani-Esfahani","year":"2014","unstructured":"Ashkani-Esfahani S, et al. Taurine improves the wound healing process in cutaneous leishmaniasis in mice model, based on Stereological parameters. Adv Biomed Res. 2014;3:204.","journal-title":"Adv Biomed Res"},{"issue":"3","key":"3847_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/jlb.58.3.299","volume":"58","author":"RW Watson","year":"1995","unstructured":"Watson RW, et al. Taurolidine, an antilipopolysaccharide agent, has immunoregulatory properties that are mediated by the amino acid taurine. J Leukoc Biol. 1995;58(3):299\u2013306.","journal-title":"J Leukoc Biol"},{"issue":"4","key":"3847_CR20","doi-asserted-by":"publisher","first-page":"e1004194","DOI":"10.1371\/journal.pmed.1004194","volume":"20","author":"KW Fung","year":"2023","unstructured":"Fung KW, et al. Prevalence and characteristics of long COVID in elderly patients: an observational cohort study of over 2 million adults in the US. PLoS Med. 2023;20(4):e1004194.","journal-title":"PLoS Med"},{"issue":"5","key":"3847_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.phrs.2009.05.006","volume":"60","author":"TM Bhavsar","year":"2009","unstructured":"Bhavsar TM, et al. Attenuating effect of taurine on lipopolysaccharide-induced acute lung injury in hamsters. Pharmacol Res. 2009;60(5):418\u201328.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3847_CR22","doi-asserted-by":"publisher","first-page":"18593","DOI":"10.1038\/s41598-019-55028-7","volume":"9","author":"MJ Coffey","year":"2019","unstructured":"Coffey MJ, et al. Gut microbiota in children with cystic fibrosis: A taxonomic and functional dysbiosis. Sci Rep. 2019;9(1):18593.","journal-title":"Sci Rep"},{"key":"3847_CR23","doi-asserted-by":"publisher","first-page":"p6869259","DOI":"10.1155\/2017\/6869259","volume":"2017","author":"X Bao","year":"2017","unstructured":"Bao X, et al. Roles of dietary amino acids and their metabolites in pathogenesis of inflammatory bowel disease. Mediators Inflamm. 2017;2017:p6869259.","journal-title":"Mediators Inflamm"},{"key":"3847_CR24","doi-asserted-by":"crossref","unstructured":"Qaradakhi T et al. The Anti-Inflammatory effect of taurine on cardiovascular disease. Nutrients, 2020. 12(9).","DOI":"10.3390\/nu12092847"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-03847-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-03847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:17:22Z","timestamp":1747282642000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmicrobiol.biomedcentral.com\/articles\/10.1186\/s12866-025-03847-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3847"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-03847-2","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were conducted following the protocols of the Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences (approval number: IACUC of AMMS-11-2022-036). The mice were anaesthetized via inhalation of 2.0% isoflurane, infected with nasal viral drops, and then naturally awakened. The endpoint of observation was defined as either natural death or a weight less than 75% of the original weight. The mice were euthanized once their weight was lower than 75% of the initial body weight via the inhalant euthanasia agent carbon dioxide. Additionally, all influenza virus infection experiments were conducted in a biosafety level 2 laboratory, and all SARS-CoV-2 infection experiments were conducted in a biosafety level 3 laboratory according to biosafety regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal ethics approval and biosafety statement"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}